Brain 'noise' may hold the keys to psychiatric treatment efficacy

Credit: Pixabay/CC0 Public Domain

It remains a central challenge in psychiatry to reliably judge whether a patient will respond to treatment. In a new study published in the journal Biological Psychiatry, researchers from Karolinska Institutet in Sweden and the Max Planck Institute for Human Development in Germany show that moment-to-moment fluctuations in brain activity can reliably predict whether patients with social anxiety disorder will be receptive to cognitive behavioral therapy (CBT).

Viable predictors of psychiatric treatment response are often sought, but remain elusive. Brain imaging techniques such as imaging (fMRI) have shown promise, but low reliability has limited the utility of typical fMRI measures as harbingers of treatment success. Although historically considered a marker of 'noise' in the brain, moment-to-moment brain signal variability continues to gain momentum as a sensitive and reliable indicator of individual differences in the effectiveness of neural function. However, neural variability had not yet been examined in relation to psychiatric treatment outcomes. 

Strongest and most reliable predictor

To do so, the research team designed a unique study; 45 patients with had their brains imaged during passive rest and emotional face viewing (a social anxiety-relevant task) in two sessions (11 weeks apart) to capture moment-to-moment neural variability. Then, patients underwent a 9-week cognitive behavioral therapy delivered via the internet. The researchers showed that brain signal variability measured during the emotional task was the strongest and most reliable predictor of treatment outcome, despite the task only taking three minutes for patients to complete.  

"Variability in brain signals is often considered measurement 'noise,' something to be eliminated prior to further analysis. We show first evidence that neural variability may be a reliable and efficient predictor of psychiatric treatment outcome, particularly when disorder-relevant task designs are utilized. We simply need to rethink our standard approaches in psychiatric neuroimaging to maximize clinical impact," says lead author Dr. Kristoffer MÃ¥nsson, clinical psychologist and researcher at the Department of Clinical Neuroscience, Karolinska Institutet.

In the next phase of their research, the authors will collect larger samples to examine whether signal variability can predict which specific treatment a patient should undergo.

Tailored treatment

"If moment-to-moment neural variability is to be worth its salt as a clinically useful predictor of treatment outcome, it needs to tell clinicians not only how much a patient will respond to a given treatment, but whether treatment A or B is better suited for them. Establishing this will be our long-term goal. In the meantime, our methods are immediately and openly available to any researcher interested in whether neural variability provides clinical utility within and beyond social anxiety disorder patients," says senior author Dr. Douglas Garrett, leader of the Lifespan Neural Dynamics Group at the Max Planck UCL Centre for Computational Psychiatry and Ageing Research in Berlin.   

More information: Kristoffer N.T. MÃ¥nsson et al, Moment-to-moment brain signal variability reliably predicts psychiatric treatment outcome, Biological Psychiatry (2021). DOI: 10.1016/j.biopsych.2021.09.026

Journal information: Biological Psychiatry
Citation: Brain 'noise' may hold the keys to psychiatric treatment efficacy (2021, October 14) retrieved 19 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

How the 'noise' in our brain influences our behavior


Feedback to editors